Related Experiment Video
Updated: Oct 16, 2025

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Pulmonary arterial hypertension: An overview
1Geraldine M. O'Leary is a clinical instructor at La Salle University in Philadelphia, Pa.
Pulmonary arterial hypertension (PAH) is a rare disease. This article covers its causes, symptoms, diagnosis, treatment, and nursing care.
Area of Science:
- Cardiology
- Pulmonology
- Medical Research
Background:
- Pulmonary arterial hypertension (PAH) is a severe condition characterized by high blood pressure in the lung arteries.
- Understanding the multifaceted aspects of PAH is crucial for effective patient management.
Purpose of the Study:
- To provide a comprehensive overview of pulmonary arterial hypertension.
- To detail the pathophysiology, risk factors, clinical presentation, diagnostic methods, and pharmacologic treatments for PAH.
- To outline essential nursing considerations for managing patients with this rare disease.
Main Methods:
- Literature review and synthesis of current research on pulmonary arterial hypertension.
- Discussion of established diagnostic criteria and treatment guidelines.
- Analysis of nursing interventions and patient care strategies.
Main Results:
- The article elaborates on the complex pathophysiology of PAH.
- It identifies key risk factors contributing to the development of PAH.
- Clinical manifestations, diagnostic approaches, and current pharmacologic treatments are detailed.
Conclusions:
- Effective management of pulmonary arterial hypertension requires a thorough understanding of its pathophysiology and a multidisciplinary approach.
- Pharmacologic treatment and specialized nursing care are vital for improving outcomes in PAH patients.
- This review serves as a resource for healthcare professionals managing patients with this rare and serious condition.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...

